-
1
-
-
0036843034
-
Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy
-
Allaqaband S, Tumuluri R, Malik AM, Gupta A, Volkert P, Shalev Y, Bajwa TK 2002 Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Cathet Cardiovasc Int 57: 279-283
-
(2002)
Cathet. Cardiovasc. Int.
, vol.57
, pp. 279-283
-
-
Allaqaband, S.1
Tumuluri, R.2
Malik, A.M.3
Gupta, A.4
Volkert, P.5
Shalev, Y.6
Bajwa, T.K.7
-
2
-
-
0037421597
-
Nephrotoxic effects in high-risk patients undergoing angiography
-
Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ 2003 Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348: 491-499
-
(2003)
N. Engl. J. Med.
, vol.348
, pp. 491-499
-
-
Aspelin, P.1
Aubry, P.2
Fransson, S.G.3
Strasser, R.4
Willenbrock, R.5
Berg, K.J.6
-
3
-
-
0038648456
-
A rapid protocol for the prevention of contrast-induced renal dysfunction: The RAPPID study
-
Baker CS, Wragg A, Kumar S, De Palma R, Baker LR, Knight CJ 2003 A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol 41: 2114-2118
-
(2003)
J. Am. Coll. Cardiol.
, vol.41
, pp. 2114-2118
-
-
Baker, C.S.1
Wragg, A.2
Kumar, S.3
De Palma, R.4
Baker, L.R.5
Knight, C.J.6
-
4
-
-
0025019379
-
Radiocontrast medium-induced declines in renal function: A role for oxygen free radicals
-
Bakris GL, Lass N, Gaber AO, Jones JD, Burnett, JC Jr 1990 Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol 258: F115-120
-
(1990)
Am. J. Physiol.
, vol.258
-
-
Bakris, G.L.1
Lass, N.2
Gaber, A.O.3
Jones, J.D.4
Burnett Jr., J.C.5
-
5
-
-
0042466568
-
Acetylcysteine for prevention of contrast nephropathy: Meta-analysis
-
Birck R, Krzossok S, Markowetz F, Schnulle P, van der Woude FJ, Braun C 2003 Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 362: 598-603
-
(2003)
Lancet
, vol.362
, pp. 598-603
-
-
Birck, R.1
Krzossok, S.2
Markowetz, F.3
Schnulle, P.4
van der Woude, F.J.5
Braun, C.6
-
6
-
-
0037371588
-
Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast
-
Boccalandro F Amhad M, Smalling RW, Sdringola S 2003 Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast. Cathet Cardiovasc Int 58: 336-342
-
(2003)
Cathet. Cardiovasc. Int.
, vol.58
, pp. 336-342
-
-
Boccalandro, F.1
Amhad, M.2
Smalling, R.W.3
Sdringola, S.4
-
7
-
-
0037125366
-
Acetyleysteine and contrast agent-associated nephrotoxicity
-
Briguori C, Manganelli F, Scarpato P, Elia PP, Golia B, Riviezzo G, Lepore S, Librera M, Villari B, Colombo A, Ricciardelli B 2002 Acetyleysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol 40: 298-303
-
(2002)
J. Am. Coll. Cardiol.
, vol.40
, pp. 298-303
-
-
Briguori, C.1
Manganelli, F.2
Scarpato, P.3
Elia, P.P.4
Golia, B.5
Riviezzo, G.6
Lepore, S.7
Librera, M.8
Villari, B.9
Colombo, A.10
Ricciardelli, B.11
-
8
-
-
0036467721
-
Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial)
-
Diaz-Sandoval LJ, Kosowsky BD, Losordo DW 2002 Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 89: 356-358
-
(2002)
Am. J. Cardiol.
, vol.89
, pp. 356-358
-
-
Diaz-Sandoval, L.J.1
Kosowsky, B.D.2
Losordo, D.W.3
-
9
-
-
18744378254
-
A randomized controlled trial of N-acetyl-cysteine to prevent contrast nephropathy in cardiac angiography
-
Durham JD, Caputo C, Dokko J, Zaharakis T, Pahlavan M, Keltz J, Dutka P, Marzo K, Maesaka JK, Fishbane S 2002 A randomized controlled trial of N-acetyl-cysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 62: 2202-2207
-
(2002)
Kidney Int.
, vol.62
, pp. 2202-2207
-
-
Durham, J.D.1
Caputo, C.2
Dokko, J.3
Zaharakis, T.4
Pahlavan, M.5
Keltz, J.6
Dutka, P.7
Marzo, K.8
Maesaka, J.K.9
Fishbane, S.10
-
10
-
-
0344945450
-
The effect of N-acetylcysteine on renal function, nitric oxide and oxidative stress after angiography
-
Efrati S, Dishy V, Averbukh M, Blatt A, Krakover R, Weisgarten J, Morrow JD, Stein MC, Golik A 2003 The effect of N-acetylcysteine on renal function, nitric oxide and oxidative stress after angiography. Kidney Int 64: 2182-2187
-
(2003)
Kidney Int.
, vol.64
, pp. 2182-2187
-
-
Efrati, S.1
Dishy, V.2
Averbukh, M.3
Blatt, A.4
Krakover, R.5
Weisgarten, J.6
Morrow, J.D.7
Stein, M.C.8
Golik, A.9
-
11
-
-
0037419923
-
Acetyleysteine for prevention of acute deterioration ofrenal function following elective coronary angiography and intervention: A randomized controlled trial
-
Kay J, Chow WH, Chan TM, Lo SK, Kwok OH, Yip A, Fan K, Lee CH, Lam WF 2003 Acetyleysteine for prevention of acute deterioration ofrenal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 289: 553-558
-
(2003)
JAMA
, vol.289
, pp. 553-558
-
-
Kay, J.1
Chow, W.H.2
Chan, T.M.3
Lo, S.K.4
Kwok, O.H.5
Yip, A.6
Fan, K.7
Lee, C.H.8
Lam, W.F.9
-
12
-
-
0034525345
-
From mucolytic to antioxidant and liver protection: New aspects in the intensive care unit career of N-acetylcysteine
-
Kiefer P, Vogt J, Radermacher P 2000 From mucolytic to antioxidant and liver protection: new aspects in the intensive care unit career of N-acetylcysteine. Crit Care Med 28: 3935-3936
-
(2000)
Crit. Care Med.
, vol.28
, pp. 3935-3936
-
-
Kiefer, P.1
Vogt, J.2
Radermacher, P.3
-
13
-
-
0346118825
-
Optimal timing of hydration to erase contrast-associated nephropathy: The OTHER CAN Study
-
Krasuski RA, Beard BM, Geoghagan JD, Thompson CM, Guidera SA 2003 Optimal timing of hydration to erase contrast-associated nephropathy: The OTHER CAN Study. J Invasive Cardiol 15: 699-702
-
(2003)
J. Invasive Cardiol.
, vol.15
, pp. 699-702
-
-
Krasuski, R.A.1
Beard, B.M.2
Geoghagan, J.D.3
Thompson, C.M.4
Guidera, S.A.5
-
15
-
-
2442527691
-
Acetylcysteine in the prevention ofcontrast-induced nephropathy after coronary angiography
-
Oldemeyer JB, Biddle WP, Wurdeman RL, Mooss AN, Cichowski E, Hilleman DE 2003 Acetylcysteine in the prevention ofcontrast-induced nephropathy after coronary angiography. Am Heart J 146: E23
-
(2003)
Am. Heart J.
, vol.146
-
-
Oldemeyer, J.B.1
Biddle, W.P.2
Wurdeman, R.L.3
Mooss, A.N.4
Cichowski, E.5
Hilleman, D.E.6
-
16
-
-
0028033015
-
Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents
-
Solomon R, Werner C, Mann D, D'Elia J, Silva P 1994 Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331: 1416-1420
-
(1994)
N. Engl. J. Med.
, vol.331
, pp. 1416-1420
-
-
Solomon, R.1
Werner, C.2
Mann, D.3
D'Elia, J.4
Silva, P.5
-
17
-
-
0034691822
-
Prevention of radiographic contrast agent-induced reductions in renal function by acetylcysteine
-
Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W 2000 Prevention of radiographic contrast agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343: 180-184
-
(2000)
N. Engl. J. Med.
, vol.343
, pp. 180-184
-
-
Tepel, M.1
van der Giet, M.2
Schwarzfeld, C.3
Laufer, U.4
Liermann, D.5
Zidek, W.6
|